“Revolutionizing Beauty: FDA Grants Approval for Evolus’ Anti-Wrinkle Gels”

Evolus Expands Product Portfolio with New Anti-Wrinkle Injectable Gels On Thursday, Evolus announced that the U.S. Food and Drug Administration has approved its two new anti-wrinkle injectable gels, marking a significant milestone for the company. This development signifies a strategic move to diversify its product offerings beyond its popular cosmetic injection Jeuveau. Revolutionizing the Anti-Aging…

Read More

Psyence Biomedical: A Shareholder Update on Our Recent Progress

Independent Valuation of PsyLabs Values Psyence Biomed’s Stake at Approximately $2 Million Debt-for-Equity Swap Strengthens Psyence Biomed’s Balance Sheet Psyence Biomedical Ltd. recently received an independent valuation of their stake in PsyLabs, which has been estimated at around $2 million. This valuation represents a significant increase in value, effectively doubling the initial investment made by…

Read More

Blockchain Association Stands Firm: A Formal Response to Senator Warren’s Criticism of Crypto Hiring Practices

The Blockchain Association defends crypto hiring practices in formal response to Senator Warren The Background The Blockchain Association recently issued a formal response to Senator Elizabeth Warren’s criticism of the crypto industry’s recruitment of former government officials. This response comes after Senator Warren questioned the motives of individuals who have transitioned from public service to…

Read More

Brixmor Property Group Reports Q4 and Full Year 2024 Financial Results: Detailed Insights into Profitable Performance

Brixmor Property Group’s Strong Tenant Demand: A Detailed Analysis Brixmor Property Group Inc., a leading owner and operator of open-air shopping malls in the United States, recently released its financial results for the period ending December 31, 2024. The company reported a net income attributable to Brixmor Property Group, Inc. of $0.27 per diluted share…

Read More

Meet the Top 500 Power Players: Acentra Health CEO Todd Stottlemyer Recognized by Virginia Business Magazine

Welcome to Acentra Health Blog CEO Todd Stottlemyer Named to Virginia 500 Power List September 03, 2024 We are excited to announce that Acentra Health’s CEO, Todd Stottlemyer, has been named to the prestigious Virginia 500 Power List by Virginia Business Magazine. This recognition highlights Todd’s significant impact and influence as a leader in the…

Read More

Addvantage Technologies Bounces Back: Regains Compliance with Nasdaq’s Minimum Bid Price Requirement

Addvantage Technologies Bounces Back: Regains Compliance with Nasdaq’s Minimum Bid Price Requirement CARROLLTON, Texas, Dec. 04, 2023 (GLOBE NEWSWIRE) — ADDvantage Technologies Group, Inc. (NASDAQ: AEY) Introduction: ADDvantage Technologies Group, Inc. has recently announced that it has regained compliance with Nasdaq’s minimum bid price requirement. This is great news for the company and its investors,…

Read More